Low Dose Decitabine in Combination With Tirelizumab Comparison of Tirelizumab in the First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
To evaluate the efficacy and safety of low-dose decitabine combined with tirelizumab in the treatment of patients with advanced esophageal squamous cell carcinoma who did not progress in first-line immunotherapy combined with chemotherapy.
Epistemonikos ID: 6a9cbcbc046729d1426b21669da486724c45ef0d
First added on: May 14, 2024